Next Article in Journal
Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Next Article in Special Issue
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron
Previous Article in Journal
“Would You Get Vaccinated against COVID-19?” The Picture Emerging from a Study on the Prevalence of SARS-CoV-2 Infection in the General Population of the Veneto Region
Previous Article in Special Issue
Evaluation of Simple Lateral Flow Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies
 
 
Article

Article Versions Notes

Vaccines 2022, 10(3), 366; https://doi.org/10.3390/vaccines10030366
Action Date Notes Link
article pdf uploaded. 26 February 2022 10:02 CET Version of Record https://www.mdpi.com/2076-393X/10/3/366/pdf-vor
article supplementary file uploaded. 26 February 2022 10:02 CET - https://www.mdpi.com/2076-393X/10/3/366#supplementary
article xml file uploaded 2 March 2022 04:52 CET Original file -
article xml uploaded. 2 March 2022 04:52 CET Update https://www.mdpi.com/2076-393X/10/3/366/xml
article pdf uploaded. 2 March 2022 04:52 CET Updated version of record https://www.mdpi.com/2076-393X/10/3/366/pdf
article html file updated 2 March 2022 04:54 CET Original file -
article html file updated 1 August 2022 02:57 CEST Update https://www.mdpi.com/2076-393X/10/3/366/html
Back to TopTop